These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24062235)

  • 21. Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
    Lismond A; Carbonnelle S; Verhaegen J; Schatt P; De Bel A; Jordens P; Jacobs F; Dediste A; Verschuren F; Huang TD; Tulkens PM; Glupczynski Y; Van Bambeke F
    Int J Antimicrob Agents; 2012 Mar; 39(3):208-16. PubMed ID: 22245497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
    Heffelfinger JD; Dowell SF; Jorgensen JH; Klugman KP; Mabry LR; Musher DM; Plouffe JF; Rakowsky A; Schuchat A; Whitney CG
    Arch Intern Med; 2000 May; 160(10):1399-408. PubMed ID: 10826451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors and pathogenic significance of bacteremic pneumonia in adult patients with community-acquired pneumococcal pneumonia.
    Kang CI; Song JH; Kim SH; Chung DR; Peck KR; Thamlikitkul V; Wang H; So TM; Hsueh PR; Yasin RM; Carlos CC; Van PH; Perera J
    J Infect; 2013 Jan; 66(1):34-40. PubMed ID: 22922634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia.
    Vila-Corcoles A; Bejarano-Romero F; Salsench E; Ochoa-Gondar O; de Diego C; Gomez-Bertomeu F; Raga-Luria X; Cliville-Guasch X; Arija V
    BMC Infect Dis; 2009 Mar; 9():36. PubMed ID: 19320989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ceftaroline Activity Against Multidrug-Resistant Streptococcus pneumoniae from U.S. Medical Centers (2014) and Molecular Characterization of a Single Ceftaroline Nonsusceptible Isolate.
    Pfaller MA; Mendes RE; Flamm RK; Jones RN; Sader HS
    Microb Drug Resist; 2017 Jul; 23(5):571-579. PubMed ID: 27918694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program.
    Castanheira M; Gales AC; Mendes RE; Jones RN; Sader HS
    Clin Microbiol Infect; 2004 Jul; 10(7):645-51. PubMed ID: 15214878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pneumococcal community-acquired pneumonia in 148 hospitalized adult patients.
    Porath A; Schlaeffer F; Pick N; Leinonen M; Lieberman D
    Eur J Clin Microbiol Infect Dis; 1997 Dec; 16(12):863-70. PubMed ID: 9495665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens.
    Song JH; Jung SI; Ki HK; Shin MH; Ko KS; Son JS; Chang HH; Kim SW; Lee H; Kim YS; Oh WS; Peck KR; Chongthaleong A; Lalitha MK; Perera J; Yee TT; Jamal F; Kamarulzaman A; Carlos CC; So T;
    Clin Infect Dis; 2004 Jun; 38(11):1570-8. PubMed ID: 15156445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of levofloxacin resistance with mortality in adult patients with invasive pneumococcal diseases: a post hoc analysis of a prospective cohort.
    Kang CI; Song JH; Kim SH; Chung DR; Peck KR; Thamlikitkul V; Wang H; So TM; Hsueh PR; Yasin RM; Carlos CC; Van PH; Perera J;
    Infection; 2013 Feb; 41(1):151-7. PubMed ID: 22821428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and microbiological characteristics of community-acquired pneumonia associated with Streptococcus pneumoniae in adult patients in Mexico.
    Echaniz-Aviles G; Garza-González E; Román-Mancha AL; Morfín-Otero R; Rodríguez-Noriega E; Ayala-Gaytán JJ; Guajardo-Lara CE; Soto-Nogueron A; Carnalla-Barajas MN; Camacho-Ortiz A
    Rev Argent Microbiol; 2019; 51(3):234-240. PubMed ID: 30635204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective, population-based surveillance of the burden of Streptococcus pneumoniae in community-acquired pneumonia in older adults, Chrzanów County, Poland, 2010 to 2012.
    Harat R; Alexander R; Gray S; Gutterman EM; Pluta J; Pride M; Shite S; Fijolek J; Kozub J
    Pneumonol Alergol Pol; 2016; 84(2):95-103. PubMed ID: 27238167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of multidrug-resistant Pneumococcal molecular epidemiology network clones among Streptococcus pneumoniae isolates from adult patients with community-acquired pneumonia in Japan.
    Imai S; Ito Y; Ishida T; Hirai T; Ito I; Maekawa K; Takakura S; Iinuma Y; Ichiyama S; Mishima M;
    Clin Microbiol Infect; 2009 Nov; 15(11):1039-45. PubMed ID: 19694764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study.
    von Gottberg A; Klugman KP; Cohen C; Wolter N; de Gouveia L; du Plessis M; Mpembe R; Quan V; Whitelaw A; Hoffmann R; Govender N; Meiring S; Smith AM; Schrag S;
    Lancet; 2008 Mar; 371(9618):1108-13. PubMed ID: 18359074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia.
    Metlay JP; Hofmann J; Cetron MS; Fine MJ; Farley MM; Whitney C; Breiman RF
    Clin Infect Dis; 2000 Mar; 30(3):520-8. PubMed ID: 10722438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia.
    Endimiani A; Brigante G; Bettaccini AA; Luzzaro F; Grossi P; Toniolo AQ
    BMC Infect Dis; 2005 Nov; 5():106. PubMed ID: 16307682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. International pneumococcal clones match or exceed the fitness of other strains despite the accumulation of antibiotic resistance.
    Rudolf D; Michaylov N; van der Linden M; Hoy L; Klugman KP; Welte T; Pletz MW;
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4915-7. PubMed ID: 21825290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, phase III clinical trials.
    Fogarty CM; Greenberg RN; Dunbar L; Player R; Marrie TJ; Kojak CM; Morgan N; Williams RR
    Clin Ther; 2001 Mar; 23(3):425-39. PubMed ID: 11318077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection.
    Yanagihara K; Izumikawa K; Higa F; Tateyama M; Tokimatsu I; Hiramatsu K; Fujita J; Kadota J; Kohno S
    Intern Med; 2009; 48(7):527-35. PubMed ID: 19336954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea.
    Shin JH; Jung HJ; Kim HR; Jeong J; Jeong SH; Kim S; Lee EY; Lee JN; Chang CL
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2625-7. PubMed ID: 17502407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hidden epidemic of macrolide-resistant pneumococci.
    Klugman KP; Lonks JR
    Emerg Infect Dis; 2005 Jun; 11(6):802-7. PubMed ID: 15963272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.